Export feasibility of hand sanitisers examined by CDSCO
The Central Drugs Standard Control Organisation (CDSCO) has instructed the Drug Controllers of all the States and Union Territories (UT) to submit the details after assessing the production capacity and…
First virtual expo on healthcare to be launched by SGCCI
SURAT: The Southern Gujarat Chamber of Commerce and Industry (SGCCI) is ready to launch country’s first virtual expo on healthcare. The main aim of virtual healthcare expo is to capture…
Jubilant & Gilead signed licensing deal for Remdesivir
US-based Gilead Sciences and India’s Jubilant Life Sciences signed a licensing agreement for production of remdesivir drug which has been identified as a potential therapy for novel coronavirus. The licensing…
Glenmark to begin Phase 3 clinical trials on Favipiravir
The Mumbai-based company Glenmark Pharmaceuticals said that it has initiated Phase 3 clinical trials on antiviral drug Favipiravir to check its effectiveness on COVID-19 patients in India. Last month, The…
68 Pharma Companies gets permit to manufacture HCQ: FDCA
AHMEDABAD: In the wake of Covid-19 pandemic, firms are rushing to manufacture hydroxychloroquine (HCQ), an anti-malarial drug used in the treatment of across the world, including India. Permit have been…
USFDA granted approval to Aurobindo Pharma for Flucytosine Capsules
Aurobindo Pharma received its final approval from the US Food & Drug Administration (USFDA) to manufacture and market Flucytosine Capsules, 250 mg and 500 mg. Flucytosine Capsules are used for…
Department of Pharmaceuticals recommends export of 2000 MT in respect of Paracetamol API
The National Pharmaceutical Pricing Authority (NPPA) has allowed six major manufacturers of paracetamol active pharmaceutical ingredients (APIs) to export 2000 metric tonnes of paracetamol API. The recommendations has been issued…
COVID-19: Strides Pharma develops antiviral tablets
New Delhi: Strides Phaarma has developed and commercialised Favipiravir antiviral tablets and stressed that the drug has gives positive outcomes in COVID-19 treatment globally. “The drug has demonstrated positive outcomes,…
Covid-19: Nursing homes to face action by BMC
In a statement issued by BMC that it will issue notices to around 25% of the total 1,496 nursing homes in the city asking them why the nursing homes should…
High time to innovate in Pharma sector to do business differently
“Its a high time that has come for pharma firms to innovate and do business differently”, says Dr Dinesh Dua, CEO and Whole-time Director, Nectar Lifesciences Ltd and chairman, Pharmexcil,…